Vertex Pharmaceuticals (VRTX) Stock: Revenue, Earnings, Margins & Valuation

Vertex Pharmaceuticals (VRTX), USA at a glance: revenue structure, segments, costs, margins and earnings from the latest published annual report, visualised as a Sankey diagram and complemented by price chart, P/E valuation and the original SEC filings. All figures in USD. Free and without signup.

Vertex Pharmaceuticals business model

The income statement of Vertex Pharmaceuticals is visualised as a Sankey diagram: from revenue through cost of revenue and operating expenses to net income. The page also shows the price chart, the price-earnings ratio of the last five fiscal years, return on equity and the company's annual and quarterly filings.

Sector: Health Care

More stock analyses like Vertex Pharmaceuticals

• Viatris stock (VTRS)
• Waters Corporation stock (WAT)
• West Pharmaceutical Services stock (WST)
• Zimmer Biomet stock (ZBH)
• Vertiv stock (VRT)
• Verizon Communications stock (VZ)
• Verisk Analytics stock (VRSK)
• Vici Properties stock (VICI)

Vertex Pharmaceuticals in detail

• Vertex Pharmaceuticals valuation: P/E, price and risk
• Vertex Pharmaceuticals earnings: quarterly revenue and EPS